Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Technical Sentiment
Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Inhibikase Therapeutics is a Sell.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 2.13, while Inhibikase Therapeutics’s (IKT) share price is $2.25, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 2.20, while Inhibikase Therapeutics’s (IKT) share price is $2.25, making it a Buy.
Inhibikase Therapeutics (IKT) Pivot Points
Classic
2.10
2.15
2.20
2.25
2.30
2.35
2.40
Fibonacci
2.15
2.19
2.22
2.25
2.29
2.32
2.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Inhibikase Therapeutics (IKT) Moving Averages
MA5
2.24Buy
2.23Buy
MA10
2.16Buy
2.17Buy
MA20
2.02Buy
2.13Buy
MA50
2.18Buy
2.20Buy
MA100
2.53Sell
2.28Sell
MA200
2.14Buy
2.05Buy
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 2.17, while Inhibikase Therapeutics’s (IKT) share price is $2.25, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 2.28, while Inhibikase Therapeutics’s (IKT) share price is $2.25, making it a Sell.
Inhibikase Therapeutics’s (IKT) stock price is $2.25 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 2.18, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $2.25 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 2.53, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $2.25 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 2.14, creating a Buy signal.
Inhibikase Therapeutics (IKT) Technical Indicators
RSI (14)
55.47
Neutral
STOCH (9,6)
86.66
Sell
STOCHRSI (14)
86.88
Sell
MACD (12,26)
0.02
Sell
ADX (14)
16.73
Buy
Williams %R
-19.83
Sell
CCI (14)
109.44
Sell
ATR (14)
0.18
-
Ultimate Oscillator
59.13
Neutral
ROC
8.70
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 55.47, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 16.73, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 109.44, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 8.70, creating a Buy signal.
FAQ
Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Buy.
What is IKT’s RSI (14)?
IKT’s RSI (14) is 55.47, which suggests IKT is a Neutral.
What is IKT’s MACD?
IKT’s MACD is 0.02, which suggests IKT is a Sell.
What is IKT’s 5-day moving average?
IKT’s 5-day moving average is 2.24, which suggests IKT is a Buy.
What is IKT’s 20-day moving average?
IKT 20-day moving average is 2.02, which suggests IKT is a Buy.
What is IKT’s 50-day moving average?
IKT’s 50-day moving average is 2.18, which suggests IKT is a Buy.
What is IKT’s 200-day moving average?
IKT’s 200-day moving average is 2.14, which suggests IKT is a Buy.
What is IKT’s Williams % R (14)?
IKT’s Williams % R (14) is -19.83, which suggests IKT is a Sell.
What is IKT’s CCI (14)?
IKT’s CCI (14) is 109.44, which suggests IKT is a Sell.